AngioDynamics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
ANGO Nasdaq 3840 www.angiodynamics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AngioDynamics, Inc.

AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026 - Jun 30th, 2026 6:00 am
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - Jun 23rd, 2026 11:06 am
AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH) - Jun 17th, 2026 6:30 am
AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect - May 28th, 2026 11:25 am
Wall Street Analysts See a 50.5% Upside in AngioDynamics (ANGO): Can the Stock Really Move This High? - May 22nd, 2026 7:55 am
Reasons to Add AngioDynamics Stock to Your Portfolio for Now - May 19th, 2026 9:47 am
AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer - May 13th, 2026 7:00 am
Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 64.23%: Read This Before Placing a Bet - May 6th, 2026 7:55 am
Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 65.75%: Here's is How to Trade - Apr 20th, 2026 7:55 am
AngioDynamics CEO Touts Debt-Free Turnaround, Auryon Share Gains, NanoKnife Launch at Needham Conf - Apr 14th, 2026 7:03 pm
AngioDynamics (ANGO) Loses 5.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Apr 10th, 2026 7:35 am
AngioDynamics (ANGO) Upgraded to Buy: Here's Why - Apr 8th, 2026 10:00 am
ANGO Stock Up in Pre-Market Post Q3 Earnings Beat, Gross Margin Down - Apr 6th, 2026 10:12 am
AngioDynamics Inc (ANGO) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amid Financial ... - Apr 2nd, 2026 1:00 pm
AngioDynamics, Inc. Q3 2026 Earnings Call Summary - Apr 2nd, 2026 10:41 am
AngioDynamics Q3 Earnings Call Highlights - Apr 2nd, 2026 7:02 am
AngioDynamics (ANGO) Reports Q3 Loss, Tops Revenue Estimates - Apr 2nd, 2026 5:15 am
AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability - Apr 2nd, 2026 4:00 am
AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference - Mar 31st, 2026 6:00 am
Several Insiders Invested In AngioDynamics Flagging Positive News - Mar 27th, 2026 7:38 am